Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study
E Gouzoulis-Mayfrank, E Habermeyer, L Hermle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 1, 1996
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites
H K Ensslin, H H Maurer, E Gouzoulis, et al.
Der Nervenarzt
|
December 31, 1997
[Metachromatic leukodystrophy simulating schizophrenia-like psychosis]
L Hermle, F W Becker, P J Egan, et al.
Neuropsychobiology
|
January 1, 1990
Psychometric, polysomnographic, and neuroendocrine measures in subjects at high risk for psychiatric disorders: preliminary results
J C Krieg, C J Lauer, L Hermle, et al.
Biological Psychiatry
|
December 1, 1992
Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research
L Hermle, M Fünfgeld, G Oepen, et al.
Der Nervenarzt
|
September 1, 1993
[Significance of historical and current hallucinogenic research in psychiatry]
L Hermle, E Gouzoulis, G Oepen, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 11, 1999
How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay
D Riemann, A König, F Hohagen, et al.
Biological Psychiatry
|
June 15, 1996
Increased activation of indirect semantic associations under psilocybin
M Spitzer, M Thimm, L Hermle, et al.
Neuropharmacology
|
August 8, 2001
Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans
M Spitzer, B Franke, H Walter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG
E Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study
E Gouzoulis-Mayfrank, E Habermeyer, L Hermle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 1, 1996
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites
H K Ensslin, H H Maurer, E Gouzoulis, et al.
Der Nervenarzt
|
December 31, 1997
[Metachromatic leukodystrophy simulating schizophrenia-like psychosis]
L Hermle, F W Becker, P J Egan, et al.
Neuropsychobiology
|
January 1, 1990
Psychometric, polysomnographic, and neuroendocrine measures in subjects at high risk for psychiatric disorders: preliminary results
J C Krieg, C J Lauer, L Hermle, et al.
Biological Psychiatry
|
December 1, 1992
Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research
L Hermle, M Fünfgeld, G Oepen, et al.
Der Nervenarzt
|
September 1, 1993
[Significance of historical and current hallucinogenic research in psychiatry]
L Hermle, E Gouzoulis, G Oepen, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 11, 1999
How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay
D Riemann, A König, F Hohagen, et al.
Biological Psychiatry
|
June 15, 1996
Increased activation of indirect semantic associations under psilocybin
M Spitzer, M Thimm, L Hermle, et al.
Neuropharmacology
|
August 8, 2001
Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans
M Spitzer, B Franke, H Walter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG
E Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
Page
of 6